GLP-1 / Metabolic

Mazdutide

Mazdutide (IBI362/LY3305677)

GLP-1/GCGR dual agonist. Chinese-developed obesity peptide with strong Phase 3 data.

Typical dose

3–9 mg

Frequency

Once weekly

Half-life

—

Route

subcutaneous

Typical vial sizes

5 mg10 mg

Sample reconstitution

5 mg vial · 2 mL bac water · 6 mg dose

Draw volume: 2.400 mL
Insulin units: 240 units
Concentration: 2.50 mg/mL
Doses per vial: 0.8

Open full calculator →

Research use only.

Information on this page is a reference log compiled from public sources and is not medical advice. Consult a licensed physician before making any decisions about your health.